{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:41:20Z","timestamp":1790430080738,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2751,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1038\/modpathol.2015.55","type":"journal-article","created":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T07:43:52Z","timestamp":1431675832000},"page":"965-976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemia"],"prefix":"10.1016","volume":"28","author":[{"given":"Olga K","family":"Weinberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Pozdnyakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Campigotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"DeAngelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Neuberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P","family":"Hasserjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2015.55_bib1","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)","volume":"100","author":"Byrd","year":"2002","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.55_bib2","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.55_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1182\/asheducation-2013.1.220","article-title":"FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?","volume":"2013","author":"Levis","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1038\/modpathol.2015.55_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"D\u00f6hner","year":"2010","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.55_bib5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMoa041974","article-title":"Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype","volume":"352","author":"Falini","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2015.55_bib6","unstructured":"Arber DA, Brunning RD, Orazi A et al. Acute myeloid leukemia with myelodysplasia related changes In: Swerdlow SH, Campo E, Harris NL et al. (eds). WHO Classification of Tumor of Haematopoietic and Lymphoid Tissues, 4th (edn). International Agency for Research on Cancer: Lyon, France, 2008, pp 124\u2013127."},{"key":"10.1038\/modpathol.2015.55_bib7","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2008-10-182782","article-title":"Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system","volume":"113","author":"Weinberg","year":"2009","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.55_bib8","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/blood-2010-04-279794","volume":"116","author":"Miesner","year":"2010","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.55_bib9","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1182\/blood-2007-08-101162","article-title":"MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients","volume":"111","author":"Wandt","year":"2008","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.55_bib10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1200\/JCO.2003.08.005","volume":"21","author":"Haferlach","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2015.55_bib11","first-page":"520","article-title":"Evaluation of the dysmyelopoiesis in 336 patients with de novo acute myeloid leukemia: major importance of dysgranulopoiesis for remission and survival","volume":"6","author":"Goasguen","year":"1992","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.55_bib12","first-page":"946","article-title":"De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance","volume":"10","author":"Gahn","year":"1996","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.55_bib13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1365-2141.1998.00766.x","article-title":"Significance of trilineage myelodysplasia in de novo acute myeloid leukaemia during remission rather than at diagnosis","volume":"101","author":"Tamura","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2015.55_bib14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1309\/EM7KCQR4GLMHRCX4","article-title":"Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival","volume":"119","author":"Arber","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2015.55_bib15","first-page":"E22","article-title":"Prognostic significance of myelodysplasia-related changes according to the WHO classification among ELN-intermediate-risk AML patients","volume":"90","author":"Devillier","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1038\/modpathol.2015.55_bib16","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/blood-2009-08-240457","article-title":"Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1","volume":"115","author":"Falini","year":"2010","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.55_bib17","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1182\/blood-2010-09-307314","article-title":"The prognostic value of multilineage dysplasia in de novo acute myeloid leukemia patients with intermediate-risk cytogenetics is dependent on NPM1 mutational status","volume":"116","author":"D\u00edaz-Bey\u00e1","year":"2010","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.55_bib18","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00277-014-2100-6","article-title":"Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1","volume":"93","author":"Rozman","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1038\/modpathol.2015.55_bib19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/leu.2014.161","article-title":"Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes","volume":"29","author":"Della Porta","year":"2015","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.55_bib20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/sj.leu.2404564","article-title":"A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification","volume":"21","author":"Verburgh","year":"2007","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.55_bib21","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2015.55_bib22","unstructured":"Brunning RD, Matutes E, Harris NL et al. Acute myeloid leukemia with multilineage dysplasia. In: Jaffe ES, Harris NL, Stein H et al. (eds) World Health Organization Classification of Tumours. International Agency for Research on Cancer (IARC): Lyons, France, 2001, pp 88\u201389."},{"key":"10.1038\/modpathol.2015.55_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2141.2007.06882.x","article-title":"Bone marrow trephine findings in acute myeloid leukaemia with multilineage dysplasia","volume":"140","author":"Ngo","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2015.55_bib24","doi-asserted-by":"crossref","first-page":"E193","DOI":"10.1002\/ajh.23808","article-title":"De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with \u226530% blasts in older adults: a Bone Marrow Pathology Group study","volume":"89","author":"Hasserjian","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1038\/modpathol.2015.55_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0145-2126(94)00134-V","article-title":"Morphological comparison of dysplastic changes between de novo acute myeloid leukemia (AML) with trilineage myelodysplasia and AML developed from de novo myelodysplastic syndromes","volume":"19","author":"Kuriyama","year":"1995","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2015.55_bib26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/ajh.23211","article-title":"Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations","volume":"87","author":"Devillier","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1038\/modpathol.2015.55_bib27","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood-2014-11-610543","article-title":"Acute myeloid leukemia is defined by distinct somatic mutations","volume":"125","author":"Lindsley","year":"2015","journal-title":"Blood"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201555","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222014053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222014053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:48:47Z","timestamp":1760230127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222014053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0893395222014053"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2015.55","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2015.55","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}